Formation Bio
Accelerating drug development through an AI-native pharmaceutical platform.
Company facts
- Founded
- 2016
- Employees
- 190
- Headquarters
- United States
- Type
- Private
- Funding
- Series D · $372M · 2024
- Subsidiaries
- Kenmare Bio, Bleecker Bio
Open positions


Associate Director/Director, Data Science, EHR AI
Lead real-world data strategy for a pharma AI company, building pipelines and harmonizing datasets to accelerate drug development and portfolio decisions.


Director, Business Development - Search & Evaluation
About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the…


Senior / Principal Data Scientist, EHR AI
Senior Data Scientist at a tech-driven pharma company, building and analyzing real-world patient data pipelines to accelerate drug development using SQL, Python, Snowflake, and generative AI.


Director, Financial Reporting
About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the…


Director/Senior Director, Product - Applied Data Science
Leads applied data science strategy to scale one-off drug-asset analyses into reusable tools/processes, bridging technical teams and business decisions in pharma/AI-driven drug development.


Associate Director, Data Engineering
Lead a data engineering team at Formation Bio, building and governing an AI‑native data platform (Snowflake, Dagster/Airflow, dbt) to support clinical operations and analytics, while coaching engineers and integrating AI tools into pipelines.


Senior Data Engineer
Builds and operates production data systems at an AI-driven pharma company — ingestion pipelines, canonical data models, and data products serving clinical operations, analytics, ML, and AI agents. Core stack is Python, SQL, Snowflake, Dagster, and dbt, with a hybrid 3-days-in-office model across NYC, Boston, and SF hubs.
